eisai d ow (Eisai Inc)
86
Structured Review
Eisai Inc
eisai d ow
Eisai D Ow, supplied by Eisai Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eisai+d+ow/d+eisai+ow/10__1158_slash_2767___9764__crc___26___0018-2-170-170
Average 86 stars, based on 1 article reviews
Eisai D Ow, supplied by Eisai Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eisai+d+ow/d+eisai+ow/10__1158_slash_2767___9764__crc___26___0018-2-170-170
Average 86 stars, based on 1 article reviews
eisai d ow - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results From the Phase 2 LEAP-005 Study Article Snippet: .. Dettman, 17 Fan Jin, 17 Roman Groisberg, 17 Ronnie Shapira-Frommer 18 1 Department of Medical Oncology and Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain (mponz@unav.es); 2 Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea (rha7655@yuhs.ac); 3 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France (gomez-roca.carlos@iuct-oncopole.fr); 4 Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain (lauraortegamoran@gmail.com); 5 The Alfred Hospital, Melbourne, VIC, Australia (s.gill@alfred.org.au); 6 Medical Oncology, Fondazione Policlinico A Gemelli IRCCS, Rome, Italy; 7 Medical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy (giampaolo.tortora@policlinicogemelli.it); 8 Sourasky Medical Center, Tel Aviv, Israel (ravitg@tlvmc.gov.il); 9 Early Phase Trial Unit, Centre Antoine Lacassagne, Nice, France; 10 Laboratory of Translational Research, Côte d'Azur University, Nice, France (Esma.SAADA-BOUZID@nice.unicancer.fr); 11 IRCCS, Humanitas Research Hospital, Milan, Italy; 12 Department of Biomedical Sciences, Humanitas University, Milan, Italy (armando.santoro@cancercenter.humanitas.it); 13 Department of Oncology, Asan Medical Center, University of |